title: Erythrodermic psoriasis.
authors.forename: N
authors.initials: N
authors.lastname: Mumoli
authors.forename: J
authors.initials: J
authors.lastname: Vitale
authors.forename: L
authors.initials: L
authors.lastname: Gambaccini
authors.forename: S
authors.initials: S
authors.lastname: Sabatini
authors.forename: B
authors.initials: B
authors.lastname: Brondi
authors.forename: M
authors.initials: M
authors.lastname: Cei
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D002117:Calcitriol / Q000031:analogs & derivatives / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000175:diagnosis* / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000175:diagnosis* / Q000188:drug therapy; D020156:Salicylic Acid / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol; D000068879:Adalimumab; D020156:Salicylic Acid